Skip to content
← Back to this collection

PUBLICATIONS · 35820112

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Nov 20
First author
Dunkel IJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dunkel IJ
      type
      Author
    2. name
      Piao J
      type
      Author
    3. name
      Chantada GL
      type
      Author
    4. name
      Banerjee A
      type
      Author
    5. name
      Abouelnaga S
      type
      Author
    6. name
      Buchsbaum JC
      type
      Author
    7. name
      Merchant TE
      type
      Author
    8. name
      Granger MM
      type
      Author
    9. name
      Jubran RF
      type
      Author
    10. name
      Weinstein JL
      type
      Author
    11. name
      Saguilig L
      type
      Author
    12. name
      Abramson DH
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dunkel IJ
      type
      Author
    2. name
      Piao J
      type
      Author
    3. name
      Chantada GL
      type
      Author
    4. name
      Banerjee A
      type
      Author
    5. name
      Abouelnaga S
      type
      Author
    6. name
      Buchsbaum JC
      type
      Author
    7. name
      Merchant TE
      type
      Author
    8. name
      Granger MM
      type
      Author
    9. name
      Jubran RF
      type
      Author
    10. name
      Weinstein JL
      type
      Author
    11. name
      Saguilig L
      type
      Author
    12. name
      Abramson DH
      type
      Author
    bibliography ids
    1. nci-bib-8c13ca09cf0708efd22ebccb
    book metadata
    content sha256
    3bee02b7b1555a9ceccd6f40251f837152c81901252d7261f70b3bf7c1a4cd1b
    document type
    citation
    dois
    1. 10.1200/JCO.21.02337
    electronic publication date
    display
    2022 Jul 12
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35820112
    immutable id
    pubmed:35820112@3bee02b7b1555a9ceccd6f40251f837152c81901252d7261f70b3bf7c1a4cd1b
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    33
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3839-3847
    volume
    40
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35820112
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      213c64e7e28ab8b5b677e3c7d24742c6da479006797aaf09c8f479900731cb58
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Nov 20
      precision
      day
      year
      2022
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35820112/
      title
      Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).

      Preserved source evidence · Not medical advice